Document Detail


Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine.
MedLine Citation:
PMID:  20436215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In failing hearts, coronary flow is normal, but the coronary flow reserve (CFR) is reduced, so demand-induced ischemia (DII) may occur in response to greater demand for O(2). The objectives of this study were: (i) to verify that dobutamine stimulation produces DII in isolated rat hearts having, like failing hearts, increased left ventricular end-diastolic pressure (LVEDP) and hence reduced CFR and (ii) to study the effects of stimulation of glucose oxidation and of inhibition of fatty acid oxidation in this new model of DII. Isolated rat hearts perfused with 11 mM glucose and 0.6 mM palmitate (or no palmitate) were studied. Stepwise increments in the volume of a balloon placed in LV resulted in reciprocal impairment of CFR, supporting the role of the extravascular compressive forces in determining CFR. CFR was 1.82+/-0.1 and 1.32+/-0.1 (p<0.05) in the hearts with LVEDP set to 5 mmHg (controls) and 40 mmHg (expanded), respectively. In controls, dobutamine increased coronary flow, myocardial oxygen consumption (MVO(2)), LVDP, mechanical efficiency, and the rates of palmitate and glucose oxidation, however, the effluent lactate concentration remained unchanged. In the expanded hearts vs. controls, dobutamine-induced increases in coronary flow and MVO(2) were reduced by approximately 50%, the increases in LVDP, efficiency, and rates of glucose and fatty acid oxidation were completely prevented, and lactate production greatly increased with dobutamine, indicating DII. Pyruvate dehydrogenase activator, dichloroacetate (DCA 1 mM) and a putative inhibitor of fatty acid beta-oxidation, trimetazidine (5 microM), both increased the rate of glucose oxidation and attenuated myocardial lactate production during DII, however they did not improve myocardial function during DII. Likewise, palmitate-free perfusion had no beneficial effect during DII although it attenuated lactate production. In the hearts subjected to palmitate-free perfusion plus DCA, lactate overproduction during DII was completely abolished, however, the deterioration of LVDP and mechanical efficiency was only partially prevented. Thus, greater demand for O(2) induces DII in the expanded hearts with reduced CFR. Lactate overproduction secondary to an imbalance between glycolysis and glucose oxidation is not a primary factor adversely affecting cardiac mechanical function during DII. Interventions shifting this balance toward glucose oxidation are not beneficial in the setting of DII in our model although they are known to effectively mitigate contractile dysfunction in the post-ischemic myocardium.
Authors:
A Skierczynska; A Beresewicz
Related Documents :
1566905 - Role of myocardial oxygen and carbon dioxide in coronary autoregulation.
7081725 - Myocardial blood flow and oxygen consumption during high-dose fentanyl anesthesia in pa...
7037025 - Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
4061275 - Improved myocardial oxygen utilization by diltiazem in patients.
17086005 - Stress testing and troponin in unstable coronary syndromes: the status trial-clinical o...
3706105 - Ventricular tachycardia induction: comparison of triple extrastimuli with an abrupt cha...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society     Volume:  61     ISSN:  1899-1505     ISO Abbreviation:  J. Physiol. Pharmacol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-05-03     Completed Date:  2010-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114501     Medline TA:  J Physiol Pharmacol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  153-62     Citation Subset:  IM    
Affiliation:
Department of Clinical Physiology, Medical Centre for Postgraduate Education, Warsaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Circulation / drug effects
Dichloroacetate / pharmacology*
Disease Models, Animal
Dobutamine / administration & dosage*
Fatty Acids / metabolism
Glucose / administration & dosage,  metabolism
Glycolysis / drug effects
Male
Myocardial Ischemia / drug therapy,  physiopathology*
Oxidation-Reduction / drug effects
Oxygen Consumption / drug effects
Palmitic Acid / administration & dosage,  metabolism
Rats
Rats, Wistar
Trimetazidine / pharmacology*
Chemical
Reg. No./Substance:
0/Fatty Acids; 13425-80-4/Dichloroacetate; 34368-04-2/Dobutamine; 50-99-7/Glucose; 5011-34-7/Trimetazidine; 57-10-3/Palmitic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The aging heart: changes in the pharmacodynamic electrophysiological response to verapamil in aged r...
Next Document:  Blockade of calcium channels and AT1 receptor prevents the hypertensive effect of calcilytic NPS 214...